Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.